Leede Financial Predicts TSE:CPH FY2027 Earnings

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) – Stock analysts at Leede Financial issued their FY2027 earnings per share (EPS) estimates for Cipher Pharmaceuticals in a report issued on Wednesday, March 19th. Leede Financial analyst D. Loe forecasts that the company will post earnings of $1.10 per share for the year. The consensus estimate for Cipher Pharmaceuticals’ current full-year earnings is $1.29 per share.

Cipher Pharmaceuticals Stock Down 3.7 %

Shares of Cipher Pharmaceuticals stock opened at C$12.65 on Monday. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. Cipher Pharmaceuticals has a 1-year low of C$7.90 and a 1-year high of C$19.69. The business’s fifty day moving average price is C$12.88 and its two-hundred day moving average price is C$14.42. The company has a market capitalization of C$227.11 million, a P/E ratio of 13.97 and a beta of 1.20.

Insider Activity at Cipher Pharmaceuticals

In other news, Director Harold Morton Wolkin sold 3,500 shares of the business’s stock in a transaction on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total value of C$47,215.00. Company insiders own 42.00% of the company’s stock.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.